These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6636376)

  • 1. Evaluation and medical management of the patient with calcium stone disease.
    Menon M; Krishnan CS
    Urol Clin North Am; 1983 Nov; 10(4):595-615. PubMed ID: 6636376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium oxalate renal stones.
    Prien EL
    Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Treatment of renal stones: cellulose phosphate or magnesium?
    Cook DA
    N Engl J Med; 1974 Nov; 291(19):1034-5. PubMed ID: 4414452
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a 5-year treatment program in patients with hyperoxaluric stones.
    Pinto B; Ruiz-Marcellán FJ; Bernshtam J
    J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of calcium oxalate stones.
    Hanson KA
    Clin Excell Nurse Pract; 2001; 5(1):21-5. PubMed ID: 11154390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.
    Pak CY; Galosy RA
    Am J Med; 1980 Nov; 69(5):681-9. PubMed ID: 7435510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent calcium stone formation with cellulose phosphate.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1980 Jan; 123(1):9-13. PubMed ID: 7351731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the stone former.
    Burns JR; Finlayson B
    Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460
    [No Abstract]   [Full Text] [Related]  

  • 13. Upper urinary tract stone analysis using X-ray diffraction: results from a tertiary referral centre in northern India.
    Ahlawat R; Goel MC; Elhence A
    Natl Med J India; 1996; 9(1):10-12. PubMed ID: 8713517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of idiopathic hypercalciuria and nephrolithiasis with sodium cellulose phosphates.
    Teotia M; Teotia SP; Singh RK; Teotia NP
    J Assoc Physicians India; 1974 Oct; 22(10):709-14. PubMed ID: 4448804
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology and management of calcium stones.
    Park S; Pearle MS
    Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.